C07J 15/00
Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially
Official title: Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
C07J15/00 (Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially) appears on 57 US grants and 48 published applications in this corpus.
Search patents in C07J- Granted patents
- 57
- Published applications
- 48
- Assignees
- 36
- Inventors
- 113
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 2 | 0 |
| 1978 | 7 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 3 | 0 |
| 1997 | 2 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 2 | 2 |
| 2003 | 0 | 1 |
| 2004 | 0 | 2 |
| 2005 | 1 | 0 |
| 2006 | 0 | 1 |
| 2007 | 1 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 2 |
| 2016 | 1 | 9 |
| 2017 | 1 | 2 |
| 2018 | 3 | 2 |
| 2019 | 7 | 1 |
| 2020 | 1 | 4 |
| 2021 | 1 | 3 |
| 2022 | 5 | 2 |
| 2023 | 1 | 5 |
| 2024 | 1 | 6 |
| 2025 | 3 | 3 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Androgen receptor modulators6 Oct 2026US 12,753,202 B2Trustees of Dartmouth College
- Steroids and methods of manufacture19 Aug 2025US 12,391,723 B2Trustees of Dartmouth College
- Irradiation process of pro vitamin D29 Apr 2025US 12,286,454 B2Fermenta Biotech Limited
- 19-nor C3,3-disubstituted C21-n-pyrazolyl steroids and methods of use thereof21 Jan 2025US 12,201,640 B2Sage Therapeutics, Inc.
- Methods for assembly of tetracyclic compounds by stereoselective C9-C10 bond formation20 Aug 2024US 12,065,465 B2Trustees of Dartmouth College
- Compositions and methods for treating cns disorders9 Apr 2026US 2026/0098053 A1Sage Therapeutics, Inc.
- 19-nor c3, 3-disubstituted c21-n-pyrazolyl steroids and methods of use thereof16 Oct 2025US 2025/0319106 A1Sage Therapeutics, Inc.
- Intermediate compound and preparation method therefor and application thereof25 Sep 2025US 2025/0296950 A1Hunan Kyf Pharmaceutical Co., Ltd.
- C-20 steroid compounds, compositions and uses thereof to treat traumatic brain injury (tbi), including concussions26 Jun 2025US 2025/0206774 A1Oragenics, Inc.
- -ent-19-norprogesterone, compositions and uses thereof to treat traumatic brain injury (TBI), including concussions-12 Dec 2024US 2024/0409576 A1Oragenics, Inc.
Most cited
By later US patents
- 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof59US 9,512,165 B2Sage Therapeutics, Inc. · 2016
- 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof46US 9,725,481 B2Sage Therapeutics, Inc. · 2017
- 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof20US 10,172,871 B2Sage Therapeutics, Inc. · 2019
- Novel 11 .beta.-alkynylphenyl-10-nor-steroids19US 4,912,097 ARoussel Uclaf · 1990
- 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof17US 10,342,810 B2Sage Therapeutics, Inc. · 2019